TOP25 728X90
SEARCH RESULTS FOR: "Tag: NBIX"
loading image
REFINE YOUR SEARCH:
RECENT
Last Week(1)
Last Month(1)
ARTICLES/BLOGS
2025(1)
2019(3)
2018(2)
2017(4)
2016(1)
2015(2)
CATEGORIES
Analyst Update(4)
Analyst Upgrades(1)
Buzz Stocks(2)
Expectational Analysis(1)
Intraday Option Activity(1)
Midday Market Check(2)
Opening View(2)
Stocks On the Move(1)

5/6/2025 10:43 AM
Biopharmaceutical giants Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Neurocrine Biosciences Inc (NASDAQ:NBIX) are fresh out of the earnings confessional, with very different results. Vertex saw a...
4/22/2019 1:23 PM
Although healthcare stocks just wrapped up a brutal week amid concerns about potential policy shifts in Washington, D.C., analysts are waxing optimistic on a pair of biotech stocks today. More specif...
3/6/2019 9:54 AM
The shares of Voyager Therapeutics Inc (NASDAQ:VYGR) jumped out of the gate, after Cantor Fitzgerald initiated coverage with an "outperform" rating and a $27 price target -- a 52% premium to last nig...
1/29/2019 9:45 AM
The shares of Voyager Therapeutics Inc (NASDAQ:VYGR) are up 44% to trade at $11.58 this morning, after the gene therapy specialist inked a development deal with Neurocrine Biosciences (NBIX). The deal...
12/12/2018 10:52 AM
Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX) are down 21% at $67.77, after the company said its Tourette's drug failed a mid-stage trial. The dramatic early drop sent NBIX stock to a new an...